Friday, May 1, 2026

Estithmar Holding : bond spectaculaire de 97 % du bénéfice net au T1 2026, à 333 millions de riyals qataris

 

Estithmar Holding Q.P.S.C. a annoncé ses résultats financiers pour le premier trimestre 2026, faisant état d’un bénéfice net de 333 millions de riyals qataris, soit une augmentation significative de 97 % par rapport à la même période de l’année précédente. Ces résultats soulignent la solidité du modèle opérationnel de la société, ainsi que l’exécution réussie de sa stratégie d’expansion.

 

La société a enregistré des revenus de 1,455 milliard de riyals qataris, contre 1,309 milliard de riyals qataris au premier trimestre 2025. Le bénéfice brut a atteint 561 millions de riyals qataris, contre 416 millions de riyals qataris, soit une progression annuelle de 35 %. L’EBITDA a augmenté de 73 % pour atteindre 473 millions de riyals qataris, tandis que le bénéfice par action a progressé de 90 % pour s’établir à 0,089 riyals qataris.

 

Ces résultats reflètent une croissance globale à travers l’ensemble des principaux indicateurs financiers, soutenue par une vision d’investissement claire et la capacité de Estithmar Holding Q.P.S.C. à concilier expansion géographique, diversification du portefeuille et efficacité opérationnelle. Les investissements internationaux annoncés au cours des périodes précédentes ont commencé à produire un impact tangible, contribuant à la croissance des revenus, à l’amélioration de la rentabilité et à l’expansion de la base d’actifs.

 

La forte croissance du bénéfice net est attribuée à l’approche rigoureuse de la Société en matière d’efficacité opérationnelle et de création de valeur, ainsi qu’à une gestion prudente du capital et à des pratiques efficaces de gestion des risques. Parallèlement, les initiatives de transformation numérique, notamment dans les domaines de l’automatisation et de l’intelligence artificielle, ont joué un rôle clé dans l’amélioration de la productivité, le renforcement de la gouvernance et l’optimisation des coûts.

 

Les résultats mettent également en évidence la contribution équilibrée des différents pôles d’activité de la Société — santé, services, tourisme et développement immobilier, ainsi qu’industries et contracting spécialisé — illustrant la réussite de chaque pôle dans la mise en œuvre de sa propre stratégie de croissance au sein d’un cadre stratégique intégré.

 

Commentant ces résultats, Juan Leon, PDG de Estithmar Holding Q.P.S.C., a déclaré :

« Les résultats du premier trimestre illustrent la solidité de notre modèle d’affaires et notre capacité à générer simultanément une croissance à la fois accélérée et durable. Plus que de simples résultats record, cette performance témoigne de la qualité de nos décisions d’investissement et de l’exécution rigoureuse de notre stratégie à travers les marchés et les secteurs. L’équilibre entre la croissance des revenus et l’amélioration de la rentabilité, soutenu par de solides performances opérationnelles et des flux de trésorerie sains, met en évidence notre efficacité, ainsi que notre capacité à transformer l’expansion en valeur tangible et durable pour les actionnaires ».

 

Pour en savoir plus, consultez le communiqué de presse dans son intégralité.

 

La seule version du communiqué qui fasse foi est celle du communiqué dans sa langue d’origine. La traduction devra toujours être confrontée au texte source, qui fera jurisprudence.



Contacts

Experian Announces Agent Trust to Power Trusted AI Driven Commerce

 First-of-its-kind human-to-agent binding service for secure AI-driven commerce, developed with a growing ecosystem of agentic commerce collaborators, including Visa, Cloudflare and Skyfire


(BUSINESS WIRE) -- Experian today announced Experian Agent Trust™, a first-of-its-kind framework that establishes a secure, verifiable link between consumers and AI agents, bringing identity, and accountability to AI-driven transactions.


As AI agents begin to search and transact autonomously, they introduce a fundamental challenge for businesses: how to trust an action when it is no longer driven by a human. Without a verified connection between humans and AI agents, autonomous commerce introduces new risks in fraud, misrepresentation, and unauthorized transactions.


Experian Agent Trust addresses this challenge through a new “Know Your Agent” (KYA) framework, extending identity verification into the age of AI. The framework ensures that agent-initiated transactions are grounded in verified consumer identity.


“Agentic commerce will not scale without trust,” said Kathleen Peters, Chief Innovation Officer at Experian. “What’s required is verifying the agent, the human behind it, and their intent to purchase. This is a natural extension of Experian’s verification role in the ecosystem. We already help define trust in financial transactions; now we’re bringing that same leadership to agentic commerce.”


Experian Agent Trust is being developed within a growing ecosystem of collaborative agentic commerce contributors, including Visa, Cloudflare, and Skyfire, who are leading the development of secure and scalable AI-driven commerce across payments, networks, and digital interactions.


Trust Stack for Agentic Commerce


Within this ecosystem, Experian’s identity capabilities is designed to complement Visa Intelligent Commerce and Trusted Agent Protocol to support a layered framework for trust and secure agentic payments.


Experian Human to Agent Binding connects verified consumers, devices and AI agents, issuing a real time trust token that validates identity, and transaction risk.


Trusted Agent Protocol allows merchants to identify and verify AI agents through Visa’s trusted network to help confirm an agent’s legitimacy and authorization to act on behalf of a consumer.


Cloudflare enforces this trust layer at the network edge, where it already powers and protects approximately 20% of the world's internet traffic, and operates the next-generation AI stack to build, secure, and scale agents.


Visa Intelligent Commerce enables secure AI commerce transactions, using network tokenization.


Skyfire offers an open, standardized way to package and exchange agent-related information across platforms, enabling interoperability and complementing existing identity and payment systems.


“Visa has spent decades earning trust across global commerce, which matters even more as AI becomes part of how transactions happen,” said Rubail Birwadker, SVP, Head of Growth Products and Partnerships at Visa. “As the ecosystem evolves and approaches like Experian’s human-to-agent identity binding capabilities emerge, Visa Intelligent Commerce and Trusted Agent Protocol are designed to provide the secure foundation for agentic commerce experiences at global scale.”


"The rise of AI agents represents one of the most significant shifts in the history of digital commerce, but it can only succeed if the underlying infrastructure is rooted in trust,” said Stephanie Cohen, Chief Strategy Officer at Cloudflare. “Cloudflare is the best place to build and secure agents. By combining our network footprint with Experian's identity expertise, we're giving any business the tools to participate in agentic commerce with confidence."


“Agentic commerce only works if merchants can confidently understand who they are transacting with, and if agents can pay as reliably as people do,” said Amir Sarhangi, CEO and co-founder of Skyfire. “Through our collaboration with Experian’s Agent Trust ecosystem and our work on the Know Your Agent (KYAPay) protocol, we’re helping enable a seamless, interoperable trust layer that brings together identity and payments to unlock the full potential of autonomous transactions.”


A consumer might ask their AI agent to find the best noise-cancelling headset for an upcoming trip. The agent can evaluate products based on the consumer’s preferences and make a recommendation, for example a Bose headphone, and prepare the transaction for approval. Once the consumer authorizes the purchase, Human to Agent Binding helps confirm that the agent is acting on behalf of a verified individual.


Experian Agent Trust is designed to work with existing payment systems and frameworks, like Trusted Agent Protocol. At the center of the framework is Human-to-Agent Binding, which creates a secure, persistent link between verified individuals, their devices, and the AI agents. This enables a continuous, auditable history between who the user is, and how the agent behaves over time.


Experian issues an Agent Trust Token that validates identity, and transaction fraud risk in real-time. Together with the Experian Agent Registry, the system maintains dynamic trust scoring for AI agents based on behavior and other risk signals.


Built for an Open Ecosystem


Experian Agent Trust services are platform-agnostic and built to scale with the evolving agent ecosystem. By establishing a trusted connection between humans and AI agents, Experian is helping define the foundation for secure, scalable agentic commerce. These capabilities extend Experian’s leadership in identity verification and fraud prevention, where its solutions help clients avoid an estimated $15–19 billion in fraud losses annually.


To learn more, visit Experian’s blog: https://www.experian.com/blogs/news/2026/04/30/experian-agent-trust/


About Experian


Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realize their financial goals and help them to save time and money.


We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.


We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 33 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.


Experian and the Experian marks used herein are trademarks or registered trademarks of Experian and its affiliates. Other product and company names mentioned herein are the property of their respective owners.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260430719198/en/



Permalink

https://www.aetoswire.com/en/news/3004202654685


Contacts

Michael Troncale

Experian Public Relations

+1 714 830 5462

michael.troncale@experian.com


Annie Russell

Experian Public Relations

+1 949 683 5243

annie.russell@experian.com

CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start the REVITALISE RCT in Europe, and Strengthening of Clinical Leadership

 


BAAR, Switzerland -

Milestones advance clinical progress and path to commercialization


(BUSINESS WIRE) -- CorFlow Therapeutics AG (CorFlow), a clinical-stage company focused on transforming the diagnosis and treatment for heart attack patients, today announced multiple milestones in advancing its clinical program and the strengthening of clinical leadership.


Phase 1 of the company’s MOCA II FDA Pivotal Trial was successfully reached after safety and performance goals were met with STEMI heart attack patients who had the proprietary PCoFI diagnostic measurement of microvascular obstruction (MVO) made during a stenting procedure, when compared to the reference standard diagnosis by cardiac MRI in the subsequent days. Phase 1 included 19 patients enrolled across 5 US and 3 European sites. MOCA II follows the FIH MOCA I study and primarily aims to validate the threshold value of the proprietary PCoFI measurement for diagnosing MVO in the setting of primary angioplasty compared to cardiac MRI. This milestone achievement, which was confirmed by the study’s independent DSMB (Data and Safety Monitoring Board) triggered the possibility for Phase 2 to begin in a larger wave of clinical trial sites in both the US and Europe.


The first patients in the MOCA II Phase II study were enrolled by Professor Marco Valgimigli at Cardiocentro Ticino Institute in Lugano, Switzerland. “I am excited to see the next generation of the CorFlow technology and advancement of the clinical program where the international pivotal study is now underway, for which the interventional cardiology community will eagerly await the results. Once the technology is readily available, it can help drive decision-making in the cath lab to improve our management of STEMI patients. Fast, accurate diagnosis of MVO is the key step we need to build from.”


CorFlow also announced that its parallel flagship clinical trial is now approved and can start enrolling patients. The novel randomized REVITALISE trial is now set to begin enrolment across UK, with France, Netherlands, and Spain following in the coming weeks. REVITALISE is intended to prospectively test the effectiveness of the proprietary CorFlow Continuous Flow Infusion System (CoFI System) to deliver therapeutic agents in treating MVO in patients undergoing primary angioplasty for acute myocardial infarction with ST segment elevation MI (STEMI). The trial intends to enroll at least 250 patients with early results expected in 2027 and data read-outs expected through 2028. The adaptive platform approach was selected due to its ability to add subsequent arms to the trial, testing the effectiveness of additional drug candidates delivered through the CorFlow system. Additional countries and research centers are also under evaluation.


Paul Mead, CEO of CorFlow, commented “With the momentum for our expanded clinical program and high interest from KOLs, we are now fortunate to be partnering with many of the top research institutions and physicians in the US and Europe to help bring the technology forward. Between both studies, we will have close to 50 top-tier hospitals engaged, each with a team motivated to see these studies succeed. Interventional cardiology, specifically in the coronary space, is at an exciting time once again with growth drivers and new options for patients. Our technology and clinical studies aim to build on that with a major step forward towards truly complete revascularization, including superior diagnosis and treatment options.”


Alongside the clinical program news, CorFlow has announced that Dr. Rick Kuntz has joined the CorFlow Board of Directors as an Observer and senior scientific advisor. Dr. Kuntz, a renowned interventional cardiologist, was a founder and Chief Scientific Officer of the Harvard Clinical Research Institute and later served at Medtronic as Chief Medical and Scientific Officer, where he oversaw medical affairs, health policy and reimbursement, clinical research activities, and corporate technology for the respected medical device leader. His experience includes guiding clinical programs for numerous technologies through market clearance and subsequent post market research for over 30 years.


CorFlow also announced the appointment of Dr. Pedro Eerdmans as Vice President Clinical. Pedro brings decades of experience from both industry, clinical research organizations, and notified bodies over his career, touching multiple medical fields. Notably, Dr. Eerdmans has helped scale medtech startups for clinical study execution, as well as spent time at larger medical companies such as Biosensors International where he served as VP Medical Affairs overseeing multiple coronary artery stent studies.


Chris O’Connell, the Chairman of the Board of CorFlow, commented, “We are thrilled with the clinical milestones that CorFlow continues to achieve, and equally excited by the added experience of our new team members. I personally had the chance to work with Dr. Kuntz at Medtronic for many years and cannot think of a better addition for CorFlow to help guide our strategic, scientific and regulatory path forward for this breakthrough technology. Our foundation will always be in medical science that puts the patient first, aiming for a new standard of care – which is possible thanks to this strengthened team and the path the company is now on with these landmark studies.”


About CorFlow Therapeutics: Founded and headquartered in Switzerland, with subsidiary operations in both Italy and the United States. The company is venture capital funded with an international VC firm syndicate, most recently with a Series B financing round announced first announced in September 2024. CorFlow aspires to be the leader in diagnostic and therapeutic solutions for restoring healthy microvascular blood flow, starting with cardiac applications for heart attack patients. Working in close partnership with scientists from the University of Bern, ETH Zurich and the University Hospital Zurich, in a collaboration funded by the Swiss Innovation Agency (Innosuisse), CorFlow continues to research applications for the unique patented technology with pharmaceutical options and new use cases.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260430413675/en/



Permalink

https://aetoswire.com/en/news/3004202654677


Contacts

Media and Scientific Contact

CorFlow Therapeutics AG

hello@corflow.ch

SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024

 BEIJING - Thursday, 30. April 2026



(BUSINESS WIRE) -- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (“SEC”). An electronic copy of the Annual Report can be accessed on SINOVAC’s investor relations website at https://www.sinovac.com/en-us/Investors and on the SEC’s website at www.sec.gov.


About SINOVAC


Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases.


The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, etc., of which 3 vaccines have been prequalified by WHO, including inactivated hepatitis A vaccine Healive®, Sabin-strain inactivated polio vaccine (sIPV), and varicella vaccine.


SINOVAC has a leading edge in developing vaccines to combat infectious disease outbreaks and was among the first to initiate R&D during major public health emergencies, including SARS, H5N1, H1N1, and COVID-19. The company developed the world’s first inactivated SARS vaccine (Phase I completed), China’s first H5N1 influenza vaccine (Panflu®), the world’s first H1N1 influenza vaccine (Panflu.1®), and CoronaVac®, the most widely used inactivated COVID-19 vaccine globally.


Beyond its marketed portfolio, the company is advancing a robust pipeline that includes combination vaccines, recombinant protein vaccines and next-generation platforms such as mRNA technologies and antibodies.


With a long-standing commitment to innovation and global health, SINOVAC is expanding its global footprint by strengthening partnerships with research institutions, international organizations, and local partners. Through broader market presence, technological cooperation, and localized production, the company aims to accelerate vaccine development and supply, enhance regional access to high-quality products, and better address unmet medical needs while improving preparedness for future pandemics.


For more information, please see the Company’s website at www.sinovac.com.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260429934070/en/



Permalink

https://www.aetoswire.com/en/news/300420202654686


Contacts

Investor and Media Contact

Sinovac Biotech Ltd.

Email: ir@sinovac.com


Andersen Consulting Strengthens Digital Transformation Capabilities with Weexa

  SAN FRANCISCO - Thursday, 30. April 2026 AETOSWire 


(BUSINESS WIRE) -- Andersen Consulting enters into a Collaboration Agreement with Weexa, a global provider of digital transformation, B2B integration, and supply chain digitalization solutions.


Headquartered in France, Weexa delivers end-to-end services that help organizations streamline, secure, and scale their digital ecosystems. The firm specializes in B2B data-flow management and digitalization, enabling seamless communication between applications both within and across organizations through technologies such as EDI, APIs, and e-invoicing. Weexa also provides SAP integration and supply chain solutions spanning warehouse and transport management, alongside strategic consulting, project delivery, and third-party application maintenance. Serving organizations across the food, retail, wholesale, logistics, transportation, automotive, healthcare, and media sectors, Weexa supports global businesses in optimizing performance while meeting evolving regulatory and digital-compliance requirements.


“Collaborating with Andersen Consulting allows us to better support clients as they navigate increasingly complex digital ecosystems,” said Jérôme Fleury, CEO of Weexa. “Collaboration is a powerful driver of business growth, and joining the Andersen platform strengthens our ability to build meaningful, long-term relationships. Our expertise in e-invoicing, combined with Andersen’s complementary tax and legal services, enables organizations to ensure compliance through well-integrated communication systems supported by a strong IT foundation.”


“The addition of Weexa further strengthens our ability to deliver integrated, technology-enabled consulting solutions to clients worldwide,” said Mark L. Vorsatz, global chairman and CEO of Andersen. “As organizations face increasing regulatory and operational complexity, the need for connected systems and reliable digital infrastructure continues to grow. Weexa’s service offerings enhance our ability to help clients drive compliance, improve efficiency, and execute digital transformation at scale.”


Andersen Consulting is a global consulting practice providing a comprehensive suite of services spanning corporate strategy, business, technology, and AI transformation, as well as human capital solutions. Andersen Consulting integrates with the multidimensional service model of Andersen Global, delivering world-class consulting, tax, legal, valuation, global mobility, and advisory expertise on a global platform with more than 50,000 professionals worldwide and a presence in over 1,000 locations through its member firms and collaborating firms. Andersen Consulting Holdings LP is a limited partnership and provides consulting solutions through its member firms and collaborating firms around the world.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260430581390/en/



Permalink

https://www.aetoswire.com/en/news/3004202654687


Contacts

mediainquiries@Andersen.com

Thursday, April 30, 2026

ABS Acquires RMC Global to Strengthen Cyber, Risk and Resilience Capabilities

 HOUSTON - Thursday, 30. April 2026 AETOSWire 



Acquisition to Deliver Stronger, More Integrated Solutions for Clients


(BUSINESS WIRE) -- ABS, through its affiliate ABSG Consulting Inc. (ABS Consulting), has today announced the acquisition of RMC Global (RMC), a leading provider of industrial cybersecurity, risk management and resiliency solutions.


The acquisition strengthens ABS Consulting’s capabilities and market position, bringing together two organizations with complementary expertise, shared values and a common mission. Combining RMC’s capabilities with ABS Consulting’s scale, technical depth and global resources, unlocks more integrated solutions for clients operating in increasingly complex risk environments.


ABS Chairman and CEO John McDonald said: “Clients are facing increasing operational risk, cyber threats, and regulatory pressure. Bringing together the expertise of RMC and ABS Consulting strengthens our ability to deliver even greater value and support for our clients through comprehensive, integrated solutions.”


He highlighted that the acquisition is both a strategic and cultural fit. RMC’s strong culture of critical infrastructure protection and industrial cybersecurity aligns closely with ABS Consulting’s focus on protecting people, assets and critical operations around the world.


He said: “ABS and RMC make a strong fit in mission and culture. Both organizations are focused on work with real-world impact. Both value expertise, practical problem solving, and long-term trust. And both are committed to helping protect critical systems, support resilience, and solve complex challenges in environments where the stakes are high.”


ABS Consulting CEO David Wechsler said: “This acquisition builds on priority areas where we see sustained client demand and long-term growth opportunity. The combination strengthens our ability to support our customers’ evolving operational risk, cyber threats, and regulatory demands, while giving us a broader platform to deliver increasingly innovative solutions.”


RMC President Vince Kuchar said: “What brought our organizations together is a shared culture, mission, and purpose: delivering practical, trusted solutions that protect critical infrastructure and critical missions, enabling resilience in the face of growing risk. By joining ABS with its 164-year mission, we are better positioned to support our clients today and to adapt alongside them in the years ahead.”


More information about ABS Consulting is available here. More information about RMC is available here.


About ABS


ABS, a global leader in classification services, is focused on delivering a safer, cleaner future for the marine and offshore industries. For over 160 years, ABS has been setting standards for safety and excellence and continues to innovate in the fields of clean technology, digitalization and artificial intelligence, providing industry-leading technical advisory services. With a global network of surveyors, engineers, technology specialists and support staff, ABS works with industry leaders including its members and clients around the world to improve safety in operational performance and efficiency with innovative solutions for the complete life cycle of marine and offshore assets.


About RMC Global


RMC is a leading provider of industrial cybersecurity, risk management, and resiliency solutions for critical infrastructure and critical missions. Committed to safeguarding national security and resilience, RMC partners with government and commercial organizations to address evolving threats and vulnerabilities.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260430164690/en/



Permalink

https://www.aetoswire.com/en/news/3004202654690


Contacts

For more information, contact ABS Media Relations: jmire@eagle.org

The Biggest Predictor of Business Growth Is Behavior

 New IDEO research reveals a gap in the behaviors that most drive growth: long-term vision, rapid experimentation, and team autonomy—with only 10% of leaders saying their company excels at the combination.


(BUSINESS WIRE) -- IDEO, the global design and innovation company, today announced the IDEO Innovation Quotient (IDEO IQ), a new report measuring how workplace behaviors drive business performance across 100 of the world’s largest companies. Those with the highest IDEO IQ scores earned nearly $20 billion in profit last year—50% higher than average and three times more than those ranked at the bottom.


The IDEO IQ surveyed 266 leaders in product and innovation roles at 100 of the world’s largest companies across the Media & Technology, Healthcare, and Consumer Goods sectors. The report is the first of its kind to draw a direct line between how companies operate internally and their financial performance. Companies were surveyed and scored based on five core behaviors, which IDEO calls the “POWER” dynamic:


Perspective: How much organizations anticipate future trends and disruptions


Ownership: How much autonomy teams have


Wavelength: How collaborative the culture is


Experimentation: How quickly businesses test new ideas


Resonance: How significantly organizations center customer needs in decisions and operations


These cultural scores were then directly correlated with business success metrics.


“Many companies understand their customers, which is critical, but far fewer have built the behaviors to act on that understanding,” said Mike Peng, CEO of IDEO. “As more organizations rely on technology for answers, advantage comes from looking further ahead, drawing on human insight, anticipating what’s next, and exploring the edges of creativity. The companies that do this are the ones taking the lead.”


The $10 billion difference


The companies pulling ahead aren’t just moving faster—they’re combining long-term perspective with the ability to act quickly. Leaders at these top-performing companies are also twice as likely to believe their organization will thrive over the next decade—and six times more likely to feel better positioned than competitors to meet future customer needs. Those in the top quintile reported:


Nearly 3× higher revenue growth.


Nearly 2× higher customer growth.


$5 billion more in annual profit (vs. the average company).


$10 billion more in annual profit (vs. bottom-quintile companies).


“It’s not that companies don’t know what they need to do,” said Becca Carroll, IDEO’s Chief Strategy Officer. “The hard part is building it into the DNA of the organization, giving teams permission to test before a concept is perfect, and making space to look beyond the next quarter.”


The majority of the leaders we surveyed (58%) report strong performance in being customer-centric—nearly triple the rate for experimentation. Far fewer say their organization consistently acts on that understanding.


This disconnect shows up most clearly in AI adoption. Only 41% of leaders say they’ve successfully adopted AI to meet customer needs, and 26% admit they’ve been too slow in adopting it overall. Companies that excel at both Perspective and Experimentation are more likely to report that AI is improving customer outcomes (52%). They are also more likely to report using AI to support profit growth (28% compared to a 16% baseline).


The opportunity gap


IDEO’s research also identified the three behaviors that drive the strongest outcomes: Experimentation, Ownership, and Perspective. They are also the ones that many companies struggle with the most. The data reveals a gap between intention and action:


Only 21% strongly agree their organizations test early versions of products and experiences with real users (Experimentation).


Only 29% strongly agree their teams have freedom to try new things (Ownership).


Only 31% strongly agree their company balances short and long-term bets (Perspective).


Leaders were more likely to have embraced Wavelength and Resonance, both crucial to success, but because they are more common behaviors, they don’t offer the same opportunity to create an outsized impact.


The IDEO IQ report will be published annually to track how the world’s largest companies evolve across these behaviors over time. It provides a framework for leaders to assess their organization’s archetype and identify opportunities for growth. To download the full report and assess your organization’s capabilities, visit https://www.ideo.com/iq.


About the research


On behalf of IDEO, B2B research specialists NewtonX surveyed 266 business leaders in product- and innovation-focused roles from 100 of the world’s biggest companies across Healthcare, Media & Technology, and Consumer Goods industries. Criteria included companies with $1 billion in revenue and 10,000+ employees, with the IDEO IQ entry restricted to the first 100 companies that responded to surveys between December 2025 and January 2026. All respondents completed the survey anonymously and independently of their employer. Where company-level IDEO IQ scores were analyzed, only companies with three or more respondents were reported (n=59 companies).


About IDEO


IDEO is a global design and innovation company. IDEO partners with organizations to tackle complex challenges, uncover new opportunities, and create meaningful and positive impact across business, society, and culture. From designing iconic products and services to crafting new ventures and building creative capabilities within organizations, IDEO’s work is rooted in empathy and experimentation. Part of kyu, a collective of strategically curated creative organizations, IDEO has offices in the US, UK, and China. Learn more at www.ideo.com.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260429978890/en/



Permalink

https://aetoswire.com/en/news/3004202654672


Contacts

Media Contact: Kathryn Green; press@ideo.com